Cadila Healthcare Ltd's subsidiary gets 5 observations from US FDA for its facility
The USFDA inspected the injectables manufacturing facility of Liva Pharmaceuticals Ltd. (Liva) which is located at Vadodara, from 20th August 2018 to 28th August 2018. Liva is a 100% subsidiary of Cadila Healthcare Ltd.
This was a product specific Pre Approval Inspection. The inspection concluded with 5 observations. Liva will respond to the USFDA within 15 days. It may be noted that at present Liva does not export any products to the US market.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.396.45 as compared to the previous close of Rs. 396.35. The total number of shares traded during the day was 143692 in over 2108 trades.
The stock hit an intraday high of Rs. 401.85 and intraday low of 393.65. The net turnover during the day was Rs. 57197497.